Primary surgery versus no surgery in synchronous metastastic breast cancer: Patient-reported outcomes of the ABCSG 28 Posytive trial

MLA

Michael Hubalek, et al. “Primary Surgery versus No Surgery in Synchronous Metastastic Breast Cancer: Patient-Reported Outcomes of the ABCSG 28 Posytive Trial.” Journal of Clinical Oncology, vol. 35, May 2017, p. 1074. EBSCOhost, https://doi.org/10.1200/jco.2017.35.15_suppl.1074.

APA

Michael Hubalek, Peter Schrenk, Anton Haid, Marija Balic, Ursula Swoboda, Richard Greil, Reinhold Fuegger, Christian F. Singer, Michael Gnant, Michael Knauer, Florian Fitzal, Viktor Wette, Lidija Soelkner, Guenther G. Steger, Christian Marth, & Vesna Bjelic-Radisic. (2017). Primary surgery versus no surgery in synchronous metastastic breast cancer: Patient-reported outcomes of the ABCSG 28 Posytive trial. Journal of Clinical Oncology, 35, 1074. https://doi.org/10.1200/jco.2017.35.15_suppl.1074

Chicago

Michael Hubalek, Peter Schrenk, Anton Haid, Marija Balic, Ursula Swoboda, Richard Greil, Reinhold Fuegger, et al. 2017. “Primary Surgery versus No Surgery in Synchronous Metastastic Breast Cancer: Patient-Reported Outcomes of the ABCSG 28 Posytive Trial.” Journal of Clinical Oncology 35 (May): 1074. doi:10.1200/jco.2017.35.15_suppl.1074.